Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Esperion craters as deaths mar atherosclerosis drug study

But the company insists its atherosclerosis candidate didn’t cause the deaths

- PMLiVE

Regeneron’s Dupixent and Praluent falls short

But CEO Len Schleifer says there’s time to fix that

- PMLiVE

Gamida Cell strengthens leadership team

Appoints Josh Hamermesh and Paul Nee

- PMLiVE

AXON appoints new head of medical communications

Emma Lemon will be based in its London, UK office

- PMLiVE

Random42 wins Queen’s Award for Enterprise

Will celebrate during the royal reception this summer

- PMLiVE

FDA looks to regulate digital tools

US regulator adds new components to digital health plan

- PMLiVE

Leo has its eyes on the prize

The company looks to the future as it bids to find novel ways to manage and defeat debilitating skin conditions

- PMLiVE

Novo Nordisk fends off Lilly’s GLP-1 challenge in Q1

Insulin specialist bounces back with encouraging signs from Ozempic launch

- PMLiVE

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

A rapid round-up of pharma, biotech and healthcare news

- PMLiVE

J&J pays $140m upfront for cancer-busting virus firm BeneVir

The total value of the deal could go above $1bn if the biotech’s candidates perform well

- PMLiVE

Profit: the ugly, dirty truth?

“My shareholders expect me to make the most profit. That's the ugly, dirty truth.”

Pharnext appoints COO

Amit Kohli joins the biopharma from Eurofins

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links